Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective

Eugenia Gianos,Dean G. Karalis,Dianna Gaballa,Rodis Paparodis,Guy L. Mintz,Maya Balakrishnan, Merle Myerson,Eliot A. Brinton,Robert A. Wild

Journal of Clinical Lipidology（2021）

引用 7|浏览9

暂无评分

摘要

•Cardiometabolic disease is linked to the development of cardiovascular disease.•APOs, PCOS and NAFLD should be recognized as markers of cardiometabolic disease.•Risk identification and optimization should be targeted throughout a woman's lifespan.•Lifestyle modification can play a significant role in disease treatment and progression.

查看译文

关键词

Cardiometabolic,Lipidology,Women's cardiovascular health,Adverse pregnancy outcomes (APO),Polycystic ovarian syndrome (PCOS),Non-alcoholic fatty liver disease (NALFD)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要